Related Experiment Videos
In-vitro evaluation of cefpodoxime
S Valentini1, G Coratza, G M Rossolini
1Dipartimento di Biologia Molecolare, Università di Siena, Italy.
The Journal of Antimicrobial Chemotherapy
|March 1, 1994
Summary
Cefpodoxime demonstrates potent in-vitro antimicrobial activity, effectively inhibiting bacterial growth even under challenging conditions like large populations and serum presence. Its bactericidal effects are rapid against key respiratory pathogens.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Cefpodoxime is a third-generation cephalosporin antibiotic.
- Understanding its efficacy in simulated physiological conditions is crucial for clinical application.
Purpose of the Study:
- To evaluate the in-vitro antimicrobial activity of cefpodoxime.
- To assess its efficacy against various clinical isolates under conditions mimicking infected tissues.
Main Methods:
- Determined Minimum Inhibitory Concentrations (MICs) for 414 clinical isolates.
- Tested cefpodoxime's activity against large bacterial inoculums (up to 10^9 cfu).
- Evaluated growth inhibition and bactericidal activity in the presence of human serum.
Main Results:
- MIC values were consistent with previous findings.
- Cefpodoxime's inhibitory effect was largely unaffected by inoculum size and human serum.
- Sub-MIC concentrations inhibited significant cell numbers for certain bacteria.
- Rapid killing of Streptococcus pneumoniae and Streptococcus pyogenes was observed at achievable plasma concentrations.
Conclusions:
- Cefpodoxime exhibits robust in-vitro antimicrobial activity.
- Its efficacy is maintained under simulated physiological conditions.
- The drug shows promise for treating infections caused by susceptible pathogens, particularly S. pneumoniae and S. pyogenes.